SAM, JSA Advised On CORONA Remedies’ ₹655 Cr IPO Pharmaceuticals December 25, 2025 Capital Markets – Equity
SAM, CAM Act On Nephrocare Health Services Limited’s IPO Healthcare December 22, 2025 Capital Markets – Equity
